We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Statements about child-resistant packaging “are most appropriately displayed on the side panels of the carton labeling and container labels” close to storage information, the agency says. Read More
A federal court in Pennsylvania ruled that a class-action lawsuit by drug distributors against Teva and AbbVie over pay-for-delay allegations can continue. Read More
Humana claims Mallinckrodt engaged in a “complex, multipart scheme involving monopoly, bribery, racketeering, fraud, and other deceptive and unfair practices.” Read More
Rep. Elijah Cummings (D-Md.) and Sen. Bernie Sanders (I-Vt.) are going after Teva, Mylan and Heritage Pharma again for allegedly obstructing a congressional inquiry into generic drug prices. Read More
The FDA is investigating the firm for failing to disclose problems with animal testing data until more than a month after the product was approved. Read More
Drugmakers were generally supportive but raised some questions and concerns in comments on the FDA’s draft guidance on increasing diversity in clinical trials. Read More